The FTSE 100 closed in negative territory on Monday, weighed down by a sharp decline in pharmaceutical giant AstraZeneca following reports of a potential mega-merger. The FTSE 100 index ended the session
More
Dividend investing remains one of the most reliable strategies for building lasting wealth through market cycles and economic uncertainty. Investors seeking steady income often turn to dividend-paying stocks as a way to
More
The question of whether equity markets are overvalued has become one of the most debated topics among investors and analysts navigating a complex economic landscape in 2026. Stock market valuations have been
More
Clarkson (CKN), the global shipbroking and shipping services group, pushed sharply higher in London trading after releasing results that impressed investors and analysts alike. The FTSE 250 firm, widely regarded as a
More
Just one in 20 British entrepreneurs believe Andy Burnham is a pro-business prime minister, according to new research from founder membership group Helm. Helm, which represents over 400 scale-up founders with a
More
Otsuka’s Voyxact Halts Kidney Function Decline In Phase 3 IgAN Trial, Strengthening FDA Approval Bid
Otsuka has reported positive full results from its Phase 3 VISIONARY trial, showing its drug Voyxact stabilised kidney function in adults with IgA nephropathy over two years. Voyxact, known clinically as sibeprenlimab-szsi,
More
The pharmaceutical industry has reached a pivotal moment at the midpoint of 2026, shaped by an accelerating dealmaking environment and rapidly shifting patient access dynamics. A widening gap in patient affordability is
More
The Office of Management and Budget published the Trump Administration’s 2026 Unified Agenda in July, outlining regulatory priorities across multiple federal agencies. Among the most significant entries, the USDA’s portion of the
More
On 28 July 2026, the Federal Communications Commission’s Public Safety and Homeland Security Bureau released Public Notice DA 26-786, adding foreign-produced advanced robotic devices to the FCC’s Covered List. The Covered List
More
Fauci’s appearance before Congress drew sharp criticism from conservative commentators after he repeatedly declined to answer questions under oath. The former director of the National Institute of Allergy and Infectious Diseases invoked
More